Type of test Blood
Normal findings
No antiplatelet antibodies identified
Test explanation and related physiology
Immune-mediated destruction of platelets may be caused either by autoantibodies directed against antigens located on the same person’s platelets or by alloantibodies that develop after exposure to transfused platelets received from a donor. These antibodies are usually directed to an antigen on the platelet membrane, such as human lymphocyte antigen (HLA) or platelet-specific antigens, such as PLA1 and PLA2.
Antibodies directed to platelets cause early destruction of the platelets and subsequent thrombocytopenia. Immunologic thrombocytopenia includes the following:
• Idiopathic thrombocytopenia purpura (ITP). Platelet-associated IgG antibodies are detected in 90% of these patients.
• Posttransfusion purpura. This is usually associated with an antibody to ABO, HLA, or PLA antigens on the RBC.
• Maternal–fetal platelet antigen incompatibility (neonatal thrombocytopenia). This occurs when the fetal platelet contains a PLA1 antigen that is absent in the mother. Neonatal thrombocytopenia can also occur if the mother has ITP autoantibodies that are passed through the placenta and destroy the fetal platelets.
• Drug-induced thrombocytopenia. Although a host of drugs are known to induce autoimmune-mediated thrombocytopenia, heparin is the most common and causes heparin-induced thrombocytopenia (HIT). There are two types of HIT that may develop. Type I HIT is generally considered a benign condition and is not antibody-mediated. In type II HIT, thrombocytopenia is usually more severe and is antibody mediated. Type II HIT is caused by an IgG antibody and usually occurs after 6 to 8 days of IV heparin therapy. The diagnosis of HIT is confirmed by identifying heparin-induced thrombocytopenia antibodies (HITAs).
Other drugs known to cause antiplatelet antibodies include analgesics (salicylates), antibiotics (cephalosporins), cimetidine, diuretics, heavy metals (e.g., gold), hypnotics, oral hypoglycemic agents, quinidine-like drugs, and many others (e.g., digoxin).
Interfering factors
• Blood transfusion may cause the development of isoantibodies to HLA antigens on the platelets or RBCs.
Procedure and patient care
• See inside front cover for Routine Blood Testing.
• Fasting: no
• Blood tube commonly used: red
Abnormal findings
Increased levels
- Idiopathic thrombocytopenia purpura
-Neonatal thrombocytopenia
- Posttransfusion purpura
- HIT
- Drug-induced thrombocytopenia
- Paroxysmal hemoglobinuria